Genocea Biosciences, Inc. Price Chart
Genocea Biosciences, Inc. GBI1.F Financial and Trading Overview
| Genocea Biosciences, Inc. stock price | 0.05 EUR |
| Previous Close | 0.05 EUR |
| Open | 0.06 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 0.05 - 0.06 EUR |
| 52 Week Range | 0.05 - 1.96 EUR |
| Volume | 4.3K EUR |
| Avg. Volume | 8.86K EUR |
| Market Cap | 2.76M EUR |
| Beta (5Y Monthly) | 2.063732 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.506 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.1 EUR |
GBI1.F Valuation Measures
| Enterprise Value | -1595257 EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.06527777 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4457477 |
| Price/Book (mrq) | 0.22274882 |
| Enterprise Value/Revenue | -0.835 |
| Enterprise Value/EBITDA | 0.029 |
Trading Information
Genocea Biosciences, Inc. Stock Price History
| Beta (5Y Monthly) | 2.063732 |
| 52-Week Change | -97.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.96 EUR |
| 52 Week Low | 0.05 EUR |
| 50-Day Moving Average | 0.39 EUR |
| 200-Day Moving Average | 0.99 EUR |
GBI1.F Share Statistics
| Avg. Volume (3 month) | 8.86K EUR |
| Avg. Daily Volume (10-Days) | 16.24K EUR |
| Shares Outstanding | 58.78M |
| Float | 54.11M |
| Short Ratio | N/A |
| % Held by Insiders | 6.22% |
| % Held by Institutions | 0.61% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | March 31, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2958.87% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -57.59% |
| Return on Equity (ttm) | -525.77% |
Income Statement
| Revenue (ttm) | 1.91M EUR |
| Revenue Per Share (ttm) | 0.03 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.64M EUR |
| EBITDA | -55668000 EUR |
| Net Income Avi to Common (ttm) | -37191000 EUR |
| Diluted EPS (ttm) | -0.506 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.14M EUR |
| Total Cash Per Share (mrq) | 0.34 EUR |
| Total Debt (mrq) | 15.49M EUR |
| Total Debt/Equity (mrq) | 125.03 EUR |
| Current Ratio (mrq) | 1.354 |
| Book Value Per Share (mrq) | 0.211 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -48186000 EUR |
| Levered Free Cash Flow (ttm) | -31454624 EUR |
Profile of Genocea Biosciences, Inc.
| Country | Germany |
| State | MA |
| City | Cambridge |
| Address | 100 Acorn Park Drive |
| ZIP | 02140 |
| Phone | 617 876 8191 |
| Website | https://www.genocea.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 74 |
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts. The plan was later approved as Chapter 11 liquidation on May 11, 2023.
Q&A For Genocea Biosciences, Inc. Stock
What is a current GBI1.F stock price?
Genocea Biosciences, Inc. GBI1.F stock price today per share is 0.05 EUR.
How to purchase Genocea Biosciences, Inc. stock?
You can buy GBI1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genocea Biosciences, Inc.?
The stock symbol or ticker of Genocea Biosciences, Inc. is GBI1.F.
How many shares does Genocea Biosciences, Inc. have in circulation?
The max supply of Genocea Biosciences, Inc. shares is 58.78M.
What is Genocea Biosciences, Inc. Price to Earnings Ratio (PE Ratio)?
Genocea Biosciences, Inc. PE Ratio is now.
What was Genocea Biosciences, Inc. earnings per share over the trailing 12 months (TTM)?
Genocea Biosciences, Inc. EPS is -0.506 EUR over the trailing 12 months.